Neptune Technologies & Bioressources
 | |
| Public | |
| Traded as |
TSX: NTB NASDAQ: NEPT |
| Industry | Biotechnology, Life Sciences |
| Founded | October 9, 1998 |
| Headquarters | Laval, Quebec, Canada |
Area served | Over 30 Countries Worldwide |
Key people | Jim Hamilton, President, CEO |
Number of employees | Est. 100 (2012) |
| Subsidiaries | Acasti Pharma |
| Website |
www.neptunebiotech.com www.neptunekrilloil.com |
Neptune Technologies & Bioressources Inc. is a life sciences company based in Laval, Quebec. The primary operations of the company are the research and development of value added natural products and the manufacturing of Neptune Krill Oil (NKO).
The Company focuses on growing consumer health markets including cardiovascular, inflammatory and neurological diseases driven by consumers taking a more proactive approach to managing health and preventing disease. The Company sponsors clinical trials aimed to demonstrate its product health benefits and to obtain regulatory approval for label health claims. Neptune’s products are marketed and distributed in over 30 countries worldwide.
See also
References
External links
This article is issued from Wikipedia - version of the Friday, June 05, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.